Artelo biosciences to present at the h.c. wainwright global life sciences conference on march 9th

La jolla, calif., march 02, 2021 (globe newswire) -- artelo biosciences, inc. (nasdaq: artl), a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that gregory gorgas, chief executive officer of artelo biosciences, will be presenting at the h.c. wainwright life sciences conference to be held virtually between march 9-10, 2021.
ARTL Ratings Summary
ARTL Quant Ranking